TaeWoong Medical USA

TaeWoong Medical USA is a prominent medical device company that designs, manufactures, and distributes innovative medical equipment focused on minimally invasive therapies. Established as part of TaeWoong Medical Co., Ltd. in 1991, the company has built a strong reputation for its advanced technologies in gastrointestinal and urological stents, as well as radiofrequency ablation (RFA) treatments. The company’s core offerings include gastrointestinal metallic stents, urology stents, and RFA treatment systems. A key product is the VIVA combo RF Generator, which has FDA clearance and is utilized in various minimally invasive surgical procedures. With over 200,000 procedures performed in more than 79 countries, TaeWoong Medical USA demonstrates significant international reach. The company is particularly recognized for its expertise in endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for treating pancreatic tumors, providing patients with effective alternatives to traditional surgery. TaeWoong Medical USA is committed to advancing patient care through innovation and technical expertise. They support healthcare professionals with comprehensive training and resources to ensure optimal clinical outcomes, reflecting their dedication to improving patient quality of life.

• Employees13
• Founded1991